01 1AbbVie Ireland NL B.V.
02 1Apotheca Company
03 1Aurore Pharmaceuticals Private Limited
04 1Azico Biophore India Private Limited
05 2Excella GmbH & Co. KG
06 1F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
07 1Fagron Inc
08 1Fagron Services BV
09 1LETCO MEDICAL, LLC
10 1LUPIN LIMITED
11 1MSN Laboratories Private Limited
12 1Medisca Inc.
13 2Peptido GmbH
14 1Professional Compounding Centers of America
15 2Sandoz GmbH
16 1Spectrum Laboratory Products, Inc.
17 1VALARY LAB PRIVATE LIMITED
01 1LEVOTHYROXINE SODIUM
02 1Levothroxine sodium
03 16Levothyroxine Sodium
04 1Levothyroxine Sodium T4
05 1Thyroidinum (Suis), Levothyroxinum, Triiodothyronine
01 2Germany
02 4India
03 1Italy
04 2Luxembourg
05 2Netherlands
06 2Switzerland
07 5U.S.A
08 1United Kingdom
09 1Blank
NDC Package Code : 68513-7155
Start Marketing Date : 2023-06-02
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 48087-0140
Start Marketing Date : 2018-12-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51552-1171
Start Marketing Date : 2004-09-01
End Marketing Date : 2026-08-06
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 46014-1013
Start Marketing Date : 2011-10-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 46014-1083
Start Marketing Date : 2011-11-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-1657
Start Marketing Date : 2012-12-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0276
Start Marketing Date : 2013-06-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (20kg/20kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 43858-460
Start Marketing Date : 2010-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 43858-410
Start Marketing Date : 2010-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 49452-4156
Start Marketing Date : 2005-09-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Levothyroxine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Levothyroxine, including repackagers and relabelers. The FDA regulates Levothyroxine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Levothyroxine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Levothyroxine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Levothyroxine supplier is an individual or a company that provides Levothyroxine active pharmaceutical ingredient (API) or Levothyroxine finished formulations upon request. The Levothyroxine suppliers may include Levothyroxine API manufacturers, exporters, distributors and traders.
click here to find a list of Levothyroxine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Levothyroxine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Levothyroxine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Levothyroxine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Levothyroxine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Levothyroxine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Levothyroxine suppliers with NDC on PharmaCompass.
We have 15 companies offering Levothyroxine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
